investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Clinical validation of the CD32b biomarker on the European market

Investigator from BioInvent (Sweden)

0 Collaborator(s)

Funding source

European Commission (Belgium)

Related projects

Michael Clarke

Self-renewal of Normal and Leukemic Stem Cells

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Clark W Distelhorst

Targeting PKM2-InsP3R interaction to treat AML

Leukaemia

Hematology and hematologic malignancies

Michael Kharas

Characterizing MSI2 in leukemia

Leukaemia

Global Noncommunicable Diseases Intiatives

Bilateral collaboration with Tunisia

Leukaemia

Stanley R. Riddell

Targeted therapy of B cell malignances with CAR-T cells of defined composition

Non-Hodgkin lymphoma Leukaemia

Derek L Stirewalt

Discovery and Optimization of AML Prognostic Biomarkers

Leukaemia

Pediatric oncology or childhood cancer

Tracy G Anthony

Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.

Leukaemia

Pediatric oncology or childhood cancer

Edward W Harhaj

Mechanisms of HTLV-I Tax Mediated NF-kB Activation

Leukaemia

Hematology and hematologic malignancies Pathology

Effie W Petersdorf

Clinical Significance of MHC Haplotypes in HCT

Leukaemia